神経陥入症候群の世界市場レポート 2025年

神経陥入症候群市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.4％で57億7,000万米ドルに成長します。今後、高齢化、末梢神経損傷（PNI）の世界の罹患率の上昇、政府の取り組みと償還政策の拡大、外傷性損傷の増加、糖尿病患者の増加などが予測期間中の成長を牽引するとみられます。予測期間中に予想される主な動向としては、製品ラインナップを拡大するための研究開発の進展、低侵襲手術技術の進歩、再生医療の発展、画像技術の改善、理学療法とリハビリテーションの革新、遺伝学と個別化医療における進行中の研究などが挙げられます。

糖尿病の有病率の増加は、神経陥入症候群市場の成長を促進すると予想されます。糖尿病は、インスリンの分泌が不十分であったり、インスリンを効果的に使用できなかったりするために、身体が血糖値の調節に苦労する慢性疾患です。糖尿病患者数の増加は、主に肥満率の上昇と座りがちなライフスタイルによるもので、いずれも2型糖尿病の罹患率増加の一因となっています。糖尿病患者の増加は、神経陥入症候群のリスクを高める。糖尿病に関連した末梢神経障害は、神経や周辺組織を弱め、圧迫に対してより脆弱にするからです。例えば、2024年6月、国民保健サービス（National Health Service）は、2023年にイングランドで50万人以上が2型糖尿病を発症するリスクがあり、糖尿病予備軍の総数は360万人以上になると報告しました。これは前年に比べ20％近く増加したことになります。このように、糖尿病人口の増加が神経陥入症候群市場の成長を促進しています。

肥満率の増加が神経陥入症候群市場の成長を促進すると予想されます。肥満とは、体格指数（BMI）が30以上であることと定義され、体脂肪が過剰であることを示します。肥満の増加は、食生活の乱れ、運動不足、座りがちなライフスタイルや不健康な食事パターンを助長する環境の影響などの要因によるところが大きいです。神経陥入症候群は、過剰な体重によって神経に余分な圧力がかかるため、肥満の人に多く見られます。例えば、2024年5月、Office for Health Improvement and Disparitiesは、2022年から2023年にかけて、英国の成人の約26.2％が肥満とともに生活しており、前年の25.9％から増加していると報告しました。その結果、肥満人口の増加が神経陥入症候群市場の拡大に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の神経陥入症候群 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の神経陥入症候群市場：成長率分析
• 世界の神経陥入症候群市場の実績：規模と成長、2019年～2024年
• 世界の神経陥入症候群市場の予測：規模と成長、2024年～2029年、2034年
• 世界の神経陥入症候群総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の神経陥入症候群市場：タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 手根管症候群
• 肘部管症候群
• 足根管症候群
• メルギア・パラステティカ
• その他のタイプ
• 世界の神経陥入症候群市場：治療法別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 医薬品
• 理学療法
• 介入手順
• 代替療法
• 世界の神経陥入症候群市場：投与経路別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 経口投与
• 注射剤投与
• 局所投与
• 世界の神経陥入症候群市場：症状の重症度別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 軽度
• 適度
• 重度
• 術後合併症
• 世界の神経陥入症候群市場、手根管症候群（CTS）のサブセグメンテーション（タイプ別）、実績と予測、2019年～2024年、2024年～2029年、2034年
• 特発性手根管症候群
• 作業関連/反復性運動障害（CTS）
• 糖尿病性神経障害関連CTS
• 外傷性または術後CTS
• 妊娠誘発性CTS
• 世界の神経陥入症候群市場、肘部管症候群の分類（タイプ別）、実績と予測、2019年～2024年、2024年～2029年、2034年
• 特発性肘部管症候群
• 反復運動誘発性肘部管症候群
• 外傷後/尺骨神経損傷関連肘部管症候群
• 変形性関節症関連肘部管症候群
• 術後肘管症候群
• 世界の神経陥入症候群市場、足根管症候群（TTS）のサブセグメンテーション、タイプ、実績と予測、2019年～2024年、2024年～2029年、2034年
• 特発性足根管症候群
• 外傷性足根管症候群
• 糖尿病関連足根管症候群
• 扁平足関連足根管症候群
• 手術後または瘢痕組織関連のTTS
• 世界の神経陥入症候群市場、メルギア・パレステティカ（MP）のサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 特発性メルギア・パレステチカ
• 肥満関連メルギア・パレステティカ
• 妊娠関連の知覚異常
• 手術後または傷跡によるメルギア・パレステティカ
• 糖尿病性神経障害関連メルギア・パレステティカ
• 世界の神経陥入症候群市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 橈骨トンネル症候群
• 胸郭出口症候群
• 腓骨神経の圧迫
• 坐骨神経の圧迫
• 腕神経叢圧迫症候群

第7章 地域別・国別分析

• 世界の神経陥入症候群市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界の神経陥入症候群市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 神経陥入症候群市場：競合情勢
• 神経陥入症候群市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Glenmark Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • Athletico Physical Therapy Overview, Products and Services, Strategy and Financial Analysis
  • Hinge Health Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Kessler Rehabilitation Center
• SPR Therapeutics
• Centaur Pharmaceuticals
• ProActive Physical Therapy & Rehabilitation
• Care24 Pvt Ltd.
• Grunenthal GmbH
• Total Performance Physical Therapy
• Back 2 Health
• Cornerstone Physical Therapy
• OrthoSport Physical Therapy & Rehabilitation
• Physio Tattva
• InvaGen Pharmaceuticals Inc.
• WEX Pharmaceuticals Inc.
• Dogwood Therapeutics Inc.
• Endo Spine Clinic

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 神経陥入症候群市場2029年：新たな機会を提供する国
• 神経陥入症候群市場2029年：新たな機会を提供するセグメント
• 神経陥入症候群市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Nerve entrapment syndrome is a condition where a nerve becomes compressed or pinched, resulting in pain, numbness, tingling, or weakness along the affected nerve's pathway. This compression typically occurs at various points in the body where nerves pass through narrow spaces, such as joints, muscles, or ligaments.

The main types of nerve entrapment syndrome include carpal tunnel syndrome, cubital tunnel syndrome, tarsal tunnel syndrome, meralgia paresthetica, and others. Carpal tunnel syndrome (CTS) occurs when the median nerve is compressed at the wrist, leading to symptoms such as numbness, tingling, and weakness in the hand. Treatment options for CTS include medications, physical therapy, interventional procedures, and alternative therapies. These treatments are administered via different routes, such as oral, injectable, or topical methods, and are used to address varying severity levels, including mild, moderate, severe, and post-surgical complications.

The nerve entrapment syndrome market research report is one of a series of new reports from The Business Research Company that provides nerve entrapment syndrome market statistics, including the nerve entrapment syndrome industry global market size, regional shares, competitors with the nerve entrapment syndrome market share, detailed nerve entrapment syndrome market segments, market trends, and opportunities, and any further data you may need to thrive in the nerve entrapment syndrome industry. This nerve entrapment syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nerve entrapment syndrome market size has grown strongly in recent years. It will grow from $4.03 billion in 2024 to $4.34 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth observed during the historic period can be attributed to factors such as the rising prevalence of peripheral neuropathy, the increasing rate of diabetes, a growing geriatric population, a rising obese population, and a higher incidence of chronic diseases.

The nerve entrapment syndrome market size is expected to see strong growth in the next few years. It will grow to $5.77 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. Looking ahead, growth during the forecast period is expected to be driven by an aging population, a rising global incidence of peripheral nerve injuries (PNI), expanding government initiatives and reimbursement policies, an increase in traumatic injuries, and a growing number of diabetic patients. Key trends anticipated in the forecast period include advancements in R&D to expand product offerings, progress in minimally invasive surgical techniques, developments in regenerative medicine, improvements in imaging technologies, innovations in physical therapy and rehabilitation, and ongoing research in genetics and personalized medicine.

The increasing prevalence of diabetes is expected to drive the growth of the nerve entrapment syndrome market. Diabetes is a chronic condition where the body struggles to regulate blood sugar levels due to either insufficient insulin production or the body's inability to effectively use insulin. The growing number of diabetic patients is primarily due to the rising rates of obesity and sedentary lifestyles, both of which contribute to the increasing incidence of type 2 diabetes. The rising number of diabetic individuals heightens the risk of nerve entrapment syndrome, as diabetes-related peripheral neuropathy weakens nerves and surrounding tissues, making them more vulnerable to compression. For example, in June 2024, the National Health Service reported that over half a million people in England were at risk of developing type 2 diabetes in 2023, bringing the total number of people with pre-diabetes to over 3.6 million. This represents a nearly 20% increase compared to the previous year. As such, the growing diabetic population is fueling the growth of the nerve entrapment syndrome market.

The increasing rate of obesity is expected to drive the growth of the nerve entrapment syndrome market. Obesity is defined as having a body mass index (BMI) of 30 or higher, indicating an excessive amount of body fat. The rise in obesity is largely attributed to factors such as poor dietary habits, lack of physical activity, and environmental influences that encourage sedentary lifestyles and unhealthy eating patterns. Nerve entrapment syndrome is more common in obese individuals due to the extra pressure placed on nerves by excess weight. For instance, in May 2024, the Office for Health Improvement and Disparities reported that approximately 26.2% of adults in the UK were living with obesity in 2022-2023, an increase from 25.9% in the previous year. As a result, the growing obese population is contributing to the expansion of the nerve entrapment syndrome market.

Rising healthcare expenditure is expected to stimulate the growth of the nerve entrapment syndrome market. Healthcare expenditure refers to the financial resources allocated to healthcare services by governments, private entities, and individuals, covering disease prevention, treatment, and management. The increase in healthcare spending is driven by the growing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and obesity, all of which require ongoing care and management. Increased healthcare spending improves the management of nerve entrapment syndrome by enhancing diagnostic capabilities, expanding access to specialized care, and fostering the development of minimally invasive treatments. Additionally, it advances surgical techniques, physiotherapy, and pain management options, leading to better recovery and outcomes for patients. For instance, in May 2024, the Office for National Statistics reported that healthcare expenditure in the UK grew by 5.6% from 2022 to 2023, compared to a 0.9% increase the previous year. Therefore, the rise in healthcare spending is driving the growth of the nerve entrapment syndrome market.

Major players in the nerve entrapment syndrome market are Pfizer Inc., Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Athletico Physical Therapy, Hinge Health, Kessler Rehabilitation Center, SPR Therapeutics, Centaur Pharmaceuticals, ProActive Physical Therapy & Rehabilitation, Care24 Pvt Ltd., Grunenthal GmbH, Total Performance Physical Therapy, Back 2 Health, Cornerstone Physical Therapy, OrthoSport Physical Therapy & Rehabilitation, Physio Tattva, InvaGen Pharmaceuticals Inc., WEX Pharmaceuticals Inc., Dogwood Therapeutics Inc., Endo Spine Clinic.

North America was the largest region in the nerve entrapment syndrome market in 2024. The regions covered in nerve entrapment syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nerve entrapment syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nerve entrapment syndrome market consists of revenues earned by entities providing services such as pain management, alternative therapies, lifestyle, and preventive counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The nerve entrapment syndrome market also includes sales of anticonvulsant drugs, neurostimulation, and neuromodulation devices, and pain management devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nerve Entrapment Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nerve entrapment syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nerve entrapment syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nerve entrapment syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Carpal Tunnel Syndrome; Cubital Tunnel Syndrome; Tarsal Tunnel Syndrome; Meralgia Parasthetica; Other Types
• 2) By Treatment Modality: Medications; Physical Therapy; Interventional Procedures; Alteative Therapies
• 3) By Administration Route: Oral Administration; Injectable Administration; Topical Administration
• 4) By Severity Of Condition: Mild; Moderate; Severe; Post-Surgical Complications
• Subsegments:
• 1) By Carpal Tunnel Syndrome (CTS): Idiopathic Carpal Tunnel Syndrome; Work-Related/Repetitive Strain CTS; Diabetic Neuropathy-Associated CTS; Traumatic or Post-Surgical CTS; Pregnancy-Induced CTS
• 2) By Cubital Tunnel Syndrome: Idiopathic Cubital Tunnel Syndrome; Repetitive Motion-Induced Cubital Tunnel Syndrome; Post-Traumatic/Ulnar Nerve Injury-Related Cubital Tunnel Syndrome; Osteoarthritis-Related Cubital Tunnel Syndrome; Post-Surgical Cubital Tunnel Syndrome
• 3) By Tarsal Tunnel Syndrome (TTS): Idiopathic Tarsal Tunnel Syndrome; Trauma-Induced Tarsal Tunnel Syndrome; Diabetes-Associated Tarsal Tunnel Syndrome; Flatfoot-Related Tarsal Tunnel Syndrome; Post-Surgical Or Scar Tissue-Related TTS
• 4) By Meralgia Paresthetica (MP): Idiopathic Meralgia Paresthetica; Obesity-Associated Meralgia Paresthetica; Pregnancy-Related Meralgia Paresthetica; Post-Surgical Or Scar-Induced Meralgia Paresthetica; Diabetic Neuropathy-Related Meralgia Paresthetica
• 5) By Other Types: Radial Tunnel Syndrome; Thoracic Outlet Syndrome; Peroneal Nerve Entrapment; Sciatic Nerve Entrapment; Brachial Plexus Compression Syndromes
• Companies Mentioned: Pfizer Inc.; Dr. Reddy's Laboratories; Glenmark Pharmaceuticals; Athletico Physical Therapy; Hinge Health
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nerve Entrapment Syndrome Market Characteristics

3. Nerve Entrapment Syndrome Market Trends And Strategies

4. Nerve Entrapment Syndrome Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Nerve Entrapment Syndrome Growth Analysis And Strategic Analysis Framework

• 5.1. Global Nerve Entrapment Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Nerve Entrapment Syndrome Market Growth Rate Analysis
• 5.4. Global Nerve Entrapment Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Nerve Entrapment Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Nerve Entrapment Syndrome Total Addressable Market (TAM)

6. Nerve Entrapment Syndrome Market Segmentation

• 6.1. Global Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carpal Tunnel Syndrome
• Cubital Tunnel Syndrome
• Tarsal Tunnel Syndrome
• Meralgia Parasthetica
• Other Types
• 6.2. Global Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Physical Therapy
• Interventional Procedures
• Alteative Therapies
• 6.3. Global Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Administration
• Injectable Administration
• Topical Administration
• 6.4. Global Nerve Entrapment Syndrome Market, Segmentation By Severity Of Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild
• Moderate
• Severe
• Post-Surgical Complications
• 6.5. Global Nerve Entrapment Syndrome Market, Sub-Segmentation Of Carpal Tunnel Syndrome (CTS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Idiopathic Carpal Tunnel Syndrome
• Work-Related/Repetitive Strain CTS
• Diabetic Neuropathy-Associated CTS
• Traumatic or Post-Surgical CTS
• Pregnancy-Induced CTS
• 6.6. Global Nerve Entrapment Syndrome Market, Sub-Segmentation Of Cubital Tunnel Syndrome, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Idiopathic Cubital Tunnel Syndrome
• Repetitive Motion-Induced Cubital Tunnel Syndrome
• Post-Traumatic/Ulnar Nerve Injury-Related Cubital Tunnel Syndrome
• Osteoarthritis-Related Cubital Tunnel Syndrome
• Post-Surgical Cubital Tunnel Syndrome
• 6.7. Global Nerve Entrapment Syndrome Market, Sub-Segmentation Of Tarsal Tunnel Syndrome (TTS), Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Idiopathic Tarsal Tunnel Syndrome
• Trauma-Induced Tarsal Tunnel Syndrome
• Diabetes-Associated Tarsal Tunnel Syndrome
• Flatfoot-Related Tarsal Tunnel Syndrome
• Post-Surgical Or Scar Tissue-Related TTS
• 6.8. Global Nerve Entrapment Syndrome Market, Sub-Segmentation Of Meralgia Paresthetica (MP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Idiopathic Meralgia Paresthetica
• Obesity-Associated Meralgia Paresthetica
• Pregnancy-Related Meralgia Paresthetica
• Post-Surgical Or Scar-Induced Meralgia Paresthetica
• Diabetic Neuropathy-Related Meralgia Paresthetica
• 6.9. Global Nerve Entrapment Syndrome Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radial Tunnel Syndrome
• Thoracic Outlet Syndrome
• Peroneal Nerve Entrapment
• Sciatic Nerve Entrapment
• Brachial Plexus Compression Syndromes

7. Nerve Entrapment Syndrome Market Regional And Country Analysis

• 7.1. Global Nerve Entrapment Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Nerve Entrapment Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nerve Entrapment Syndrome Market

• 8.1. Asia-Pacific Nerve Entrapment Syndrome Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nerve Entrapment Syndrome Market

• 9.1. China Nerve Entrapment Syndrome Market Overview
• 9.2. China Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nerve Entrapment Syndrome Market

• 10.1. India Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nerve Entrapment Syndrome Market

• 11.1. Japan Nerve Entrapment Syndrome Market Overview
• 11.2. Japan Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nerve Entrapment Syndrome Market

• 12.1. Australia Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nerve Entrapment Syndrome Market

• 13.1. Indonesia Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nerve Entrapment Syndrome Market

• 14.1. South Korea Nerve Entrapment Syndrome Market Overview
• 14.2. South Korea Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nerve Entrapment Syndrome Market

• 15.1. Western Europe Nerve Entrapment Syndrome Market Overview
• 15.2. Western Europe Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nerve Entrapment Syndrome Market

• 16.1. UK Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nerve Entrapment Syndrome Market

• 17.1. Germany Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nerve Entrapment Syndrome Market

• 18.1. France Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nerve Entrapment Syndrome Market

• 19.1. Italy Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nerve Entrapment Syndrome Market

• 20.1. Spain Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nerve Entrapment Syndrome Market

• 21.1. Eastern Europe Nerve Entrapment Syndrome Market Overview
• 21.2. Eastern Europe Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nerve Entrapment Syndrome Market

• 22.1. Russia Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nerve Entrapment Syndrome Market

• 23.1. North America Nerve Entrapment Syndrome Market Overview
• 23.2. North America Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nerve Entrapment Syndrome Market

• 24.1. USA Nerve Entrapment Syndrome Market Overview
• 24.2. USA Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nerve Entrapment Syndrome Market

• 25.1. Canada Nerve Entrapment Syndrome Market Overview
• 25.2. Canada Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nerve Entrapment Syndrome Market

• 26.1. South America Nerve Entrapment Syndrome Market Overview
• 26.2. South America Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nerve Entrapment Syndrome Market

• 27.1. Brazil Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nerve Entrapment Syndrome Market

• 28.1. Middle East Nerve Entrapment Syndrome Market Overview
• 28.2. Middle East Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nerve Entrapment Syndrome Market

• 29.1. Africa Nerve Entrapment Syndrome Market Overview
• 29.2. Africa Nerve Entrapment Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Nerve Entrapment Syndrome Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Nerve Entrapment Syndrome Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nerve Entrapment Syndrome Market Competitive Landscape And Company Profiles

• 30.1. Nerve Entrapment Syndrome Market Competitive Landscape
• 30.2. Nerve Entrapment Syndrome Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Glenmark Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Athletico Physical Therapy Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hinge Health Overview, Products and Services, Strategy and Financial Analysis

31. Nerve Entrapment Syndrome Market Other Major And Innovative Companies

• 31.1. Kessler Rehabilitation Center
• 31.2. SPR Therapeutics
• 31.3. Centaur Pharmaceuticals
• 31.4. ProActive Physical Therapy & Rehabilitation
• 31.5. Care24 Pvt Ltd.
• 31.6. Grunenthal GmbH
• 31.7. Total Performance Physical Therapy
• 31.8. Back 2 Health
• 31.9. Cornerstone Physical Therapy
• 31.10. OrthoSport Physical Therapy & Rehabilitation
• 31.11. Physio Tattva
• 31.12. InvaGen Pharmaceuticals Inc.
• 31.13. WEX Pharmaceuticals Inc.
• 31.14. Dogwood Therapeutics Inc.
• 31.15. Endo Spine Clinic

32. Global Nerve Entrapment Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nerve Entrapment Syndrome Market

34. Recent Developments In The Nerve Entrapment Syndrome Market

35. Nerve Entrapment Syndrome Market High Potential Countries, Segments and Strategies

• 35.1 Nerve Entrapment Syndrome Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Nerve Entrapment Syndrome Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Nerve Entrapment Syndrome Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer